Serum-biomarker-based population screening model for hepatocellular carcinoma
Wenmin Liao(Sun Yat-sen University), Chaofeng Li(Sun Yat-sen University), Zhonglian He, Chenyang Feng(Sun Yat-sen University), Wenbin Lin(Sun Yat-sen University), Peisong Chen(Sun Yat-sen University), Wei Wei(Zhujiang Hospital), Ying Sun(Johns Hopkins University), Ruizhi Wang(Nanjing University of Aeronautics and Astronautics), Yuying Liu(Tianjin University of Science and Technology), Meifang He(Sun Yat-sen University), Shuqin Dai(Sun Yat-sen University), Zixian Wang(Sun Yat-sen University)
Cited by 0
Related Papers
Sorafenib Plus Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, and Leucovorin vs Sorafenib Alone for Hepatocellular Carcinoma With Portal Vein Invasion
|JAMA Oncology|2019|559
Gasdermin E–mediated target cell pyroptosis by CAR T cells triggers cytokine release syndrome
|Science Immunology|2020|555
Tumor-Repopulating Cells Induce PD-1 Expression in CD8+ T Cells by Transferring Kynurenine and AhR Activation
|Cancer Cell|2018|535
Chloroquine modulates antitumor immune response by resetting tumor-associated macrophages toward M1 phenotype
|Nature Communications|2018|520
Circulating tumor DNA methylation profiles enable early diagnosis, prognosis prediction, and screening for colorectal cancer
|Science Translational Medicine|2020|447